Our laboratory studies class I fusion proteins to understand how they are attacked by host factors during expression in the secretory pathway. Class I fusion proteins are expressed from HIV-1, influenza virus, Ebola virus, and SARS-COV-2 to mediate virus entry and initiate infection. Although these viruses belong to different families, their fusion proteins share identical features in structure and biosynthesis.